No Data
BTIG Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $200
BTIG Sticks to Their Buy Rating for Zoetis (ZTS)
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Monday Market Green Like the Irish, But for How Long: Live Stock News
New York Manufacturing Hits Low, Inflation Fears Rise
Zoetis Inc.'s (NYSE:ZTS) Business Is Yet to Catch Up With Its Share Price
Expand
